Information about Paeme Pharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0812.307.989

VAT liability
Yes
Established
16-06-2009
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Business and other management consultancy activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Paeme Pharma

2024 2023 2022 2021
Profit/Loss 32,934 14 % 28,912 25 % 23,160 226 % 7,105
Equity 528,473 7 % 495,540 6 % 466,627 5 % 443,467
Gross margin 53,014 15 % 46,217 14 % 40,585 -13 % 46,580

Publications from Paeme Pharma

Date Publication
28-12-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Miscellaneous - Resignations - Appointments (NL)
21-12-2010 Registered Office (NL)
18-06-2009 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Paeme Pharma?
The VAT number of Paeme Pharma is BE 0812.307.989.
Wat is the PEPPOL ID of Paeme Pharma?
The PEPPOL ID of Paeme Pharma is 0208:0812307989. Log in or start a free trial to see the full overview.
When was Paeme Pharma founded?
Paeme Pharma was founded on 16-06-2009.
What is the address of Paeme Pharma?
The current registered office of Paeme Pharma is located at Avenue De L'arbre Ballon 115/10, 1020 Bruxelles.
When was the last time Paeme Pharma filed their annual financial statements?
The most recent financial statements of Paeme Pharma were filed on 03-09-2025.
How many employees does Paeme Pharma have?
There are currently no employees working at Paeme Pharma or no workforce information is available.
What is the annual turnover of Paeme Pharma?
At the time of its most recent financial statements, Paeme Pharma did not publish any turnover figures. Paeme Pharma reported a gross margin of €53,013.58.